ap01 (inhaled pirfenidone) — Topline data
H2 2027
Topline data are anticipated in the second half of 2027.Source filing
AVALYN PHARMA INC · Data as of 2026-09-08
H2 2027
Topline data are anticipated in the second half of 2027.Source filing
in late 2027
Topline data are anticipated in late 2027.Source filing
Sep 5–Sep 9
In September 2026, the Company plans to present two abstracts at the ERS Congress in Barcelona, Spain.Source filing